Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China
- PMID: 35448947
- PMCID: PMC9026662
- DOI: 10.1186/s12872-022-02612-x
Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China
Abstract
Aims: To characterize surgical valvular heart diseases (VHDs) in China and disclose regional variations in VHD surgeries by analyzing the data derived from the Chinese Cardiac Surgery Registry (CCSR).
Methods and results: From January 2016 to December 2018, we consecutively collected the demographic information, clinical characteristics and outcomes of 38,131 adult patients undergoing valvular surgery in China. We sought to assess the quality of VHD surgery by examining in-hospital deaths of all patients from 7 geographic regions. Using a hierarchical generalized linear model, we calculated the risk-standardized mortality rate (RSMR) of each region. By comparing VHD characteristics and RSMRs, we pursued an investigation into regional variations. The mean age was 54.4 ± 12.4 years, and 47.2% of the patients were females. Among cases, the number of aortic valve surgeries was 9361 (24.5%), which was less than that of mitral valve surgeries (n = 14,506, 38.0%). The number of concurrent aortic and mitral valve surgeries was 6984 (18.3%). A total of 4529 surgical VHD patients (11.9%) also underwent coronary artery bypass grafting (CABG) surgery. The overall in-hospital mortality rate was 2.17%. The lowest RSMR, 0.91%, was found in the southwest region, and the highest RSMR, 3.99%, was found in the northeast.
Conclusion: Although the overall valvular surgical mortality rate in large Chinese cardiac centers was in line with high-income countries, there were marked regional variations in the characteristics and outcomes of surgical VHD patients across China.
Keywords: RSMR; Regional variation; Surgery; VHD; Valvular heart disease.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Primary regional disparities in clinical characteristics, treatments, and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China: Insights from the China-VHD Study.Chin Med J (Engl). 2025 Apr 20;138(8):937-946. doi: 10.1097/CM9.0000000000003570. Epub 2025 Mar 18. Chin Med J (Engl). 2025. PMID: 40097371 Free PMC article. Clinical Trial.
-
Coronary artery bypass graft: contemporary heart surgery center performance in China.Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):214-21. doi: 10.1161/CIRCOUTCOMES.111.962365. Epub 2012 Mar 6. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22396587 Free PMC article.
-
Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States.JAMA Cardiol. 2017 Dec 1;2(12):1322-1331. doi: 10.1001/jamacardio.2017.4003. JAMA Cardiol. 2017. PMID: 29117319 Free PMC article.
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
Non-cardiac surgery in patients with valvular heart disease.Heart. 2022 Jul 13;108(15):1171-1178. doi: 10.1136/heartjnl-2021-319160. Heart. 2022. PMID: 34815334 Review.
Cited by
-
Transcatheter aortic valve replacement in China - a review of the available evidence.AsiaIntervention. 2024 Jul 26;10(2):110-118. doi: 10.4244/AIJ-D-23-00049. eCollection 2024 Jul. AsiaIntervention. 2024. PMID: 39070975 Free PMC article. Review.
-
A New Risk Score for Predicting Postoperative Mortality in Suspected Heart Failure Patients Undergoing Valvular Surgery.Rev Cardiovasc Med. 2023 Feb 2;24(2):38. doi: 10.31083/j.rcm2402038. eCollection 2023 Feb. Rev Cardiovasc Med. 2023. PMID: 39077403 Free PMC article.
-
Protocol for the PORT study: short-term perioperative rehabilitation to improve outcomes in cardiac valvular surgery - a randomised control trial.BMJ Open. 2023 Dec 21;13(12):e074837. doi: 10.1136/bmjopen-2023-074837. BMJ Open. 2023. PMID: 38135333 Free PMC article.
-
A Three-Day Prehabilitation Program is Cost-Effective for Preventing Pulmonary Complications after Heart Valve Surgery: A Health Economic Analysis of a Randomized Trial.Rev Cardiovasc Med. 2024 Sep 10;25(9):323. doi: 10.31083/j.rcm2509323. eCollection 2024 Sep. Rev Cardiovasc Med. 2024. PMID: 39355593 Free PMC article.
References
-
- Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale C, Maggioni A, Petersen S, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame J, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos E, Weidinger F, Achenbach S. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716–799. doi: 10.1093/eurheartj/ehab892. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical